Lupin Obtains USFDA Approval for Ranluspec Biosimilar Based on Lucentis
Pharmaceutical company Lupin Ltd announced on Thursday (June 4) that it has obtained approval from the United States Food and Drug…
Lupin introduces 5 and 10 mg dapagliflozin tablets in the US following FDA clearance.
Pharma giant Lupin Ltd announced on Friday (April 10) the launch of dapagliflozin tablets in 5 mg and 10 mg doses in the United States. This…
Lupin Receives Tentative Approval from US FDA for Extended-Release Oxcarbazepine Tablets
On Saturday (June 7), drug manufacturer Lupin Ltd announced that it has secured tentative approval from the U.S. Food and Drug Administration…